Indo Us Bio-Tech Ltd

Indo Us Bio-Tech Ltd maintains a strong capital structure with a debt-to-equity ratio of 0.19, indicating a conservative leverage position relative to its equity base. The company's liquidity position is characterized as medium, with a current ratio of 5.31, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's cash and equivalents amount to INR 2,478,440, which is significantly lower than its long-term debt of INR 148,362,670, resulting in a net cash deficit. In terms of profitability, the company's return on equity (ROE) is 20.72%, and its return on assets (ROA) is 16.63%, both of which are strong indicators of efficient use of equity and assets to generate profits. These metrics suggest that the company is performing well compared to industry norms, although specific industry medians are not provided in the data. The company's revenue is primarily concentrated in the Seed Cultivation, processing, and trading segment, with a distribution network spanning multiple Indian states and export markets in the United States, New Jersey, Palestine, Cameroon, and Kuwait. This geographic and product diversification helps mitigate regional and product-specific risks. Looking at the growth trajectory, the company has demonstrated a positive operating cash flow of INR 14,193,290 and a free cash flow of INR 160,017,870, indicating its ability to generate cash from operations and fund future growth. The capital expenditure of INR -8,621,000 suggests that the company is not currently investing heavily in new capital assets, which may indicate a focus on optimizing existing operations. The risk assessment highlights a medium liquidity risk, primarily due to the company's net cash deficit after accounting for total debt. The dilution risk is assessed as low, with no immediate pressure for share issuance or dilution. The company's conservative debt levels and strong profitability metrics contribute to a relatively stable financial position. Recent events and filings have not indicated any significant changes in the company's operations or financial strategy. The company continues to focus on its core business of seed production and marketing, with no major new initiatives or strategic shifts reported in the latest financial data.